Takeda inked a collaboration deal to develop and commercialize Portal's needle-free drug delivery device for use with some of Takeda's biologic medicines. Source: BioSpace

Bristol-Myers is initiating a Phase III clinical trial of BMS-986205 with nivolumab in patients with advanced melanoma. Source: BioSpace

The increased funding showcases investor confidence in Counsyl’s leading genetic screening products and business model. Source: BioSpace

A little more than two years after acquiring Sprout, Valeant is selling off the developer of the female sex drive drug Addyi. Source: BioSpace

Shares of Teva are up more than 5 percent this morning after Israeli media reported billionaire businessman Len Blavatnik is considering taking a large stock position in the pharma giant.…

The round was led by new investor Abingworth with participation from another new investor, 5AM Ventures, LSP and Versant Ventures. Source: BioSpace

Shares of TherapeuticsMD have shot up more than 51 percent in morning trading after the FDA reversed course on its rejection of that company's vaginal pain medication. Source: BioSpace

Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace

Patrick Soon-Shiong touted sales of his closely scrutinized test without revealing the purchaser was on his payroll. Source: BioSpace

Varian said it will replace linear accelerators in the oncology departments of Rigshospitalet and Herlev Hospital with 15 advanced Varian TrueBeam and Halcyon treatment machines and two ViewRay MRIdian MR-Guided…